In this study, we identified several drug compounds, such as 3′-Azido-3′-deoxythymidine, ajmaline, azacyclonol, and dirithromycin, that might target COX7C and modulate metabolic pathways in RA. Here, COX7C is linked to rheumatoid arthritis.